Solution structure of mu-conotoxin PIIIA, a preferential inhibitor of persistent tetrodotoxin-sensitive sodium channels
about
Structure and function of μ-conotoxins, peptide-based sodium channel blockers with analgesic activityStructural basis for tetrodotoxin-resistant sodium channel binding by mu-conotoxin SmIIIAA novel µ-conopeptide, CnIIIC, exerts potent and preferential inhibition of NaV1.2/1.4 channels and blocks neuronal nicotinic acetylcholine receptorsMammalian Neuronal Sodium Channel Blocker μ-Conotoxin BuIIIB Has a Structured N-Terminus That Influences PotencyA novel 4/7-conotoxin LvIA from Conus lividus that selectively blocks 3 2 vs. 6/ 3 2 3 nicotinic acetylcholine receptorsTransforming conotoxins into cyclotides: Backbone cyclization of P-superfamily conotoxinsBioactive marine drugs and marine biomaterials for brain diseasesBiochemical characterization of kappaM-RIIIJ, a Kv1.2 channel blocker: evaluation of cardioprotective effects of kappaM-conotoxins.Structure, dynamics, and selectivity of the sodium channel blocker mu-conotoxin SIIIA.Systematic study of binding of μ-conotoxins to the sodium channel NaV1.4.The M-superfamily of conotoxins: a review.Mechanism of μ-conotoxin PIIIA binding to the voltage-gated Na+ channel NaV1.4.Human β-defensin 4 with non-native disulfide bridges exhibit antimicrobial activity.Binding modes of μ-conotoxin to the bacterial sodium channel (NaVAb)Conotoxins targeting neuronal voltage-gated sodium channel subtypes: potential analgesics?NMR-based mapping of disulfide bridges in cysteine-rich peptides: application to the mu-conotoxin SxIIIAStructurally diverse μ-conotoxin PIIIA isomers block sodium channel NaV 1.4.Incorporation of post-translational modified amino acids as an approach to increase both chemical and biological diversity of conotoxins and conopeptides.Analgesic Effects of GpTx-1, PF-04856264 and CNV1014802 in a Mouse Model of NaV1.7-Mediated Pain.Structurally minimized mu-conotoxin analogues as sodium channel blockers: implications for designing conopeptide-based therapeutics.Analgesic effects of clinically used compounds in novel mouse models of polyneuropathy induced by oxaliplatin and cisplatin.chi-Conopeptide MrIA partially overlaps desipramine and cocaine binding sites on the human norepinephrine transporter.Structure--activity relationships of hainantoxin-IV and structure determination of active and inactive sodium channel blockers.µ-Conotoxins Modulating Sodium Currents in Pain Perception and Transmission: A Therapeutic Potential.Neuronally micro-conotoxins from Conus striatus utilize an alpha-helical motif to target mammalian sodium channels.Marine Toxins That Target Voltage-gated Sodium Channels.Re-engineering the μ-conotoxin SIIIA scaffold.Determination of the μ-Conotoxin PIIIA Specificity Against Voltage-Gated Sodium Channels from Binding Energy Calculations.NMR Structure of μ-Conotoxin GIIIC: Leucine 18 Induces Local Repacking of the N-Terminus Resulting in Reduced Na Channel Potency
P2860
Q27021886-254368D5-7505-4831-9546-07B64458EF9DQ27642020-952B573B-61D0-4585-B304-3F17940DD482Q27676650-939FFA90-E03A-4DA6-9F63-CE436C2BBE83Q27677218-3FE34511-1D16-485A-AB77-5C5542D57D00Q27681218-12660F6F-2CE9-41AB-9F41-C20CF8D62981Q27701553-523C8D02-109D-4EE6-A5A2-0BC346069911Q33736687-95321FA5-0549-4A2B-9E80-9B1C04C14369Q33832653-286635A5-165C-435B-841B-541FFDC17C63Q34362601-5F5AA2E1-9C98-4067-85CE-1D790E62EEFEQ34792648-120B3C69-5702-420B-8A68-CDAC592ADE8BQ34999276-40BC5CAD-4B3A-41E3-8F2D-433345AC669BQ35133771-92337C41-5845-4FFE-9480-D0D85563F5C9Q35580348-DD343A89-3F76-4916-93C8-57107D7FB4E4Q35743263-A5D6128D-1154-4CC7-B8B1-0C0B9D778031Q36432810-7E48DD20-4604-4CF8-9BEC-74FDA1CEC4E9Q37150906-FFF7FDB3-9EFD-44DB-96B2-162742CAE3AAQ37992537-C44525EB-0A88-4482-8205-97B10CDBF812Q38162112-313989BA-75C1-49E0-8792-38F5FC8A37E1Q39587472-614B35AB-296E-46BF-B0F6-D5444441CAEAQ41444544-33B4EFFA-C7BC-4CE8-A30F-EC33EF023937Q41852990-CB6E2472-6662-45FC-8E75-D8E46ACE164CQ44499448-8398BBD6-39F9-4F4D-8DFF-328E9195F8F6Q44939687-19ECABDD-3774-4CD0-A887-35E0587DF6DFQ45384168-D6CE1E2A-A47C-4519-9622-748FB785B412Q46560325-AB170B96-EA83-465F-BAED-E9F219EB548EQ46776095-2E8D74A8-169A-417A-8885-A817F886D8E0Q47861997-DAB57661-33CD-4D3E-89DF-047E1AC7770AQ55010535-5A0B1467-8952-4FF5-AEFF-7499DE02F9F2Q58582851-BF963912-1B12-43C8-9B3F-FE280EEF01C5
P2860
Solution structure of mu-conotoxin PIIIA, a preferential inhibitor of persistent tetrodotoxin-sensitive sodium channels
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Solution structure of mu-conot ...... oxin-sensitive sodium channels
@ast
Solution structure of mu-conot ...... oxin-sensitive sodium channels
@en
Solution structure of mu-conot ...... oxin-sensitive sodium channels
@nl
type
label
Solution structure of mu-conot ...... oxin-sensitive sodium channels
@ast
Solution structure of mu-conot ...... oxin-sensitive sodium channels
@en
Solution structure of mu-conot ...... oxin-sensitive sodium channels
@nl
prefLabel
Solution structure of mu-conot ...... oxin-sensitive sodium channels
@ast
Solution structure of mu-conot ...... oxin-sensitive sodium channels
@en
Solution structure of mu-conot ...... oxin-sensitive sodium channels
@nl
P2093
P50
P356
P1476
Solution structure of mu-conot ...... oxin-sensitive sodium channels
@en
P2093
Anna K Hammarström
Denise Adams
Justine M Hill
Katherine J Nielsen
Linda Thomas
Michael Watson
Paul F Alewood
Peter W Gage
P304
P356
10.1074/JBC.M201611200
P407
P577
2002-07-26T00:00:00Z